TARIS BIOMEDICAL LLC
Limited Liability Company · WILMINGTON, United States · LEI 5493002ZCTVUIFE8J557
LEI lapsed
Summary
TARIS BIOMEDICAL LLC is registered in the United States. Its legal form is Limited Liability Company. According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 55 of them in the United States. The LEI was first issued on 9 Jun 2020 and the record was last updated on 11 Aug 2026. It has lapsed: renewal was due by 10 Aug 2026. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 10 Aug 2026 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2022, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 11 Aug 2026.
Company details
| Legal form | Limited Liability Company |
|---|---|
| Register | · Register website |
| Registration number | 5580746 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 19801 WILMINGTON, United States |
| Headquarters address | 113 Hartwell Avenue, 02421 Lexington, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 4 Aug 2014 |
| LEI | 5493002ZCTVUIFE8J557 |
| LEI status | lapsed |
| LEI first issued | 9 Jun 2020 |
| LEI record last updated | 11 Aug 2026 |
| Next LEI renewal | 10 Aug 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
TARIS BIOMEDICAL LLC this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 1 Jan 2022 to 31 Dec 2022 | 1 Jan 2022 to 31 Dec 2022 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 26 May 2020 | 26 May 2020 |
| Recorded at GLEIF since | 9 Jun 2020 | 9 Jun 2020 |
| Last updated | 11 Aug 2026 | 11 Aug 2026 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (97)
- ACCLARENT, INC. United States
- ACTELION PHARMACEUTICALS US, INC. United States lapsed
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
- CORDIS FINANCING CORPORATION United States lapsed
- DEPUY SYNTHES PRODUCTS, INC. United States
- DEPUY SYNTHES SALES, INC. United States
- DEPUY SYNTHES, INC. United States